NICOLE SAVELL: Open Payments
NPI 1699293886 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 42 payments from 6 companies in 2025. Trend: 2023 $463 · 2024 $946 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $420 |
| ABBVIE INC. | 11 | $181 |
| GENZYME CORPORATION | 7 | $166 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $141 |
| GlaxoSmithKline, LLC. | 4 | $113 |
| Medtronic, Inc. | 2 | $53 |
Products named: DUPIXENT, NEFFY, NUCALA, UBRELVY, QULIPTA, PROPEL, CREON.
Industry payments across TX — which companies pay providers there.
